Did you know that a $10,000 investment with GN Store Nord (the Danish company that owns the Beltone hearing aid product line) three years after their acquisition of Beltone in 2000, would have yielded you a profit of $30,000?

Or what about Phonak, a hearing aid and assistive technology company, that saw its stock price rise nearly 600% since January 2003? A $10,000 investment there would’ve made you about $43,000 richer. And a $10,000 Siemens investment would have netted you about $9,000 in profit.

Jaguar, anyone?

But what about the cochlear implant companies? A $10,000 investment with Cochlear, an Australian company, in January 2003, would be worth 144% more today. And one would’ve lost money had he or she invested in Boston Scientific, owner of Advanced Bionics, another CI maker, at the time of acquisition in January 2004. A $10,000 investment then would leave you hanging dry today with about only $5,000.

In summary, this would be what your portfolio would look like had you made the above stock picks:

Company Date Initial Investment Est. Current Value
Cochlear 01/03 $10,000 $14,400
Phonak 01/03 $10,000 $53,600
Siemens 01/03 $10,000 $19,400
GN Store Nord 01/03 $10,000 $39,800
Boston Scientific 01/04 $10,000 $5,600
Total: $132,800
Cost Basis: $50,000
Gain: $82,800
Change: +266% 166%

According to a Goldman Sachs analyst who wears a CI, “Due to the popularity of the CI, it is possible that CI manufacturers are getting the attention of larger health care companies and as a result, are becoming prime acquisition targets.”

Needless to say, the CI business, overall, is good–but the question we need to ask–is this business sustainable? From a product life cycle point of view, could it be that the CI is at its peak?

PLC.gif

Could investors be cashing out their CI stock portfolios and be waiting on the sidelines for the next big thing? At the time of writing, some of the above companies were already taking a hit.

Who knows. But perhaps they’re like me and waiting to see who reaches the finish line first with the first “totally implantable cochlear implant” (TICI) that’s expected to come onto the market. Christine Writer, of Cochlear, Ltd., the CI market leader, has confirmed that the TICI is among its current R&D efforts. The University of Miami’s Cochlear Implant Team is among several other groups claiming to be working on this next-generation CI.

Will deaf, hard-of-hearing and especially late-deafened people be rushing to their audiologists once this invisible implant arrives on the shelves ? Is this a subset of the deaf community that would realize that they no longer would need to worry about being stared at on Metro nor would they be ever subject to Borg-like, “what’s that on your head” or god forbid, “You’re no longer deaf enough!” comments upon discovery of the CI.

Anyway, perhaps its one of these companies above that’ll win this race and be able to capitalize on the vanity of deaf and hard of hearing Americans. Perhaps it’ll be a fledgling company.

And if you’re wondering–would I ever get one? I’m undecided if not indifferent to the idea.

Robert Rice is not a financial advisor nor does he own any shares in the companies mentioned in this blog. No content published on this blog constitutes a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. To the extent any of the content published on this blog may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.


© Copyrighted material. This article cannot be copied, reproduced or redistributed without the express written consent of the author. As with every blog on this website, this blog does not reflect the opinion of DeafDC.com.